These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 1615333)
41. Erythropoietin--improving the quality of life of dialysis patients. Kionka C J Biotechnol; 1995 Nov; 43(1):73-4. PubMed ID: 8573324 [No Abstract] [Full Text] [Related]
43. [Treatment of anemia in chronically dialyzed patients]. Moynot A Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055 [No Abstract] [Full Text] [Related]
44. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin]. Fandrey JK; Jelkmann WE Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021 [TBL] [Abstract][Full Text] [Related]
45. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin]. Adam Z; Krejcí M; Vorlícek J Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717 [TBL] [Abstract][Full Text] [Related]
46. The adverse effects of recombinant human erythropoietin therapy. Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088 [No Abstract] [Full Text] [Related]
47. Erythropoietin use in peritoneal dialysis patients. Zimmerman SW; Johnson CA Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078 [TBL] [Abstract][Full Text] [Related]
48. Recombinant human erythropoietin. Experimental and clinical applications. Nielsen OJ Dan Med Bull; 1991 Oct; 38(5):355-70. PubMed ID: 1802621 [No Abstract] [Full Text] [Related]
49. [The significance of erythropoietin for nephrology]. Watzinger U; Peer G; Barnas U; Mayer G; Luger A; Kovarik J; Graf H Wien Klin Wochenschr; 1990 Mar; 102(5):125-30. PubMed ID: 2181782 [TBL] [Abstract][Full Text] [Related]
50. Clinical spectrum of iron overload, novel uses of iron chelators, and potential treatment of pediatric anemias with erythropoietin. Introduction. Cairo MS Am J Pediatr Hematol Oncol; 1990; 12(1):1-3. PubMed ID: 2178456 [No Abstract] [Full Text] [Related]
51. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy. Lundin AP Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517 [TBL] [Abstract][Full Text] [Related]